about
Quantitative proteomics and terminomics to elucidate the role of ubiquitination and proteolysis in adaptive immunitySharpening Host Defenses during Infection: Proteases Cut to the Chase.Discovery of a proteolytic flagellin family in diverse bacterial phyla that assembles enzymatically active flagella.C-terminal truncation of IFN-γ inhibits proinflammatory macrophage responses and is deficient in autoimmune disease.Granzyme B is elevated in autoimmune blistering diseases and cleaves key anchoring proteins of the dermal-epidermal junction.Launching the C-HPP pilot project for functional characterization of identified proteins with no known functionProgress on Identifying and Characterizing the Human Proteome: 2018 Metrics from the HUPO Human Proteome ProjectGlobal Profiling of Proteolysis from the Mitochondrial Amino Terminome during Early Intrinsic Apoptosis Prior to Caspase-3 ActivationToward Completion of the Human Proteome Parts List: Progress Uncovering Proteins That Are Missing or Have Unknown Function and Developing Analytical MethodsHydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 AminopeptidasesProteomic and N-Terminomic TAILS Analyses of Human Alveolar Bone Proteins: Improved Protein Extraction Methodology and LysargiNase Digestion Strategies Increase Proteome Coverage and Missing Protein IdentificationAn allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patientAdvances in Identifying and Characterizing the Human ProteomeDeep Profiling of the Cleavage Specificity and Human Substrates of Snake Venom Metalloprotease HF3 by Proteomic Identification of Cleavage Site Specificity (PICS) Using Proteome Derived Peptide Libraries and Terminal Amine Isotopic Labeling of SubstMatrix metalloproteinases in the CNS: interferons get nervousProgress on Identifying and Characterizing the Human Proteome: 2019 Metrics from the HUPO Human Proteome ProjectNovel Human Aminopeptidase N Inhibitors: Discovery and Optimization of Subsite Binding InteractionsMaster Sculptor at Work: Enteropathogenic Escherichia coli Infection Uniquely Modifies Mitochondrial Proteolysis during Its Control of Human Cell Death
P50
Q28069531-D8FBB65C-9D3D-40E4-A6F9-EBE77B7F8924Q39127087-26DD1325-0D31-4792-95A6-165C203B46B3Q41194835-48CFD025-3E5D-42B3-B5A3-C803315CB3ACQ55382749-7D90D6AE-2844-455E-A8E9-C40E4783CDB7Q55428949-E516BAF6-AA3A-4B79-BF29-D19495918EF8Q57058325-89D0FD50-CE63-4467-AC19-BC27AE921509Q57267856-C28CA481-BEC2-4EAC-AF06-9CF7F3070EE7Q58104831-5B33CE2D-7EA4-4FE2-868B-711E16F19A00Q59790575-A19859AC-52F8-4D68-B462-252BBAD1430DQ90409201-5F419FF7-D826-4E6B-8A10-D1AA6A61A94BQ90633847-2B61B15F-7DBD-4358-BEDD-4EF5595B76E5Q91259871-63034B1E-D832-4091-9110-0568AF2ABBB3Q91727371-BADCE033-319D-4E54-8EFD-25D1A16B80FDQ92130783-FE0B6157-2B68-4F9C-A8EA-7BB006F3E445Q92528708-489F61F8-F9CE-4AC6-927D-190B50E68FC5Q92726015-5E7CC754-1A04-4CD8-A819-362D95CC05DFQ93102642-614F5919-6177-48AF-966D-A3126D214DFBQ96125536-D5BA29ED-1110-4925-A42D-921889C7877D
P50
description
researcher
@en
name
Christopher M Overall
@en
type
label
Christopher M Overall
@en
prefLabel
Christopher M Overall
@en
P108
P31
P496
0000-0001-5844-2731